INS and type 2 diabetes mellitus: Likewise, it was shown that a methylation risk score based on blood DNA methylation at cg06500161 and cg11024682 enables stratification of the cohorts into insulin-resistant and insulin-sensitive or lean and obese subjects [121], indicating that DNA methylation in blood cells is a valid approach for stratification of risk groups and may be used for T2D risk prediction.